Metrikler
Yayın
94
Açık Erişim
4
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2021 - Devam Ediyor
2021 - Devam EdiyorDoktora
Ankara Yıldırım Beyazıt Üniversitesi, Sağlık Bilimleri Enstitüsü, Pharmacology PhD, Türkiye
2017 - 2021
2017 - 2021Tıpta Uzmanlık
Sağlık Bilimleri Üniversitesi, Dr.Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Hematology Fellowship, Türkiye
2012 - 2016
2012 - 2016Tıpta Uzmanlık
İstanbul Medeniyet Üniversitesi, Internal Medicine Residency, Internal Medicine Residency, Türkiye
2012 - 2014
2012 - 2014Yüksek Lisans
Sakarya Üniversitesi, Master of Business Administration (MBA), Master of Business Administration (MBA), Türkiye
2005 - 2011
2005 - 2011Lisans
Eskişehir Osmangazi Üniversitesi, Tıp Fakültesi, Medicine, Türkiye
Yaptığı Tezler
2016
2016Tıpta Uzmanlık
Kronik hemodiyaliz hastalarında malnütrisyon ile diyaliz yeterliliği ilişkisi
İstanbul Medeniyet Üniversitesi
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Hematoloji
Akademik Ünvanlar / Görevler
2023 - Devam Ediyor
2023 - Devam EdiyorDoç. Dr.
Dokuz Eylül Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
2021 - 2022
2021 - 2022HEMATOLOJİ UZMAN DOKTOR
DR. ABDURRAHMAN YURTASLAN ANKARA ONKOLOJİ EĞİTİM VE ARAŞTIRMA HASTANESİ, HEMATOLOJİ UZMAN DOKTOR
2017 - 2021
2017 - 2021HEMATOLOJİ YAN DAL ASİSTAN DOKTOR
DR. ABDURRAHMAN YURTASLAN ANKARA ONKOLOJİ EĞİTİM VE ARAŞTIRMA HASTANESİ, HEMATOLOJİ YAN DAL ASİSTAN DOKTOR
2016 - 2017
2016 - 2017İÇ HASTALIKLARI UZMAN DOKTOR
ARDAHAN DEVLET HASTANESİ, İÇ HASTALIKLARI UZMAN DOKTOR
2012 - 2016
2012 - 2016İÇ HASTALIKLARI ASİSTAN DOKTOR
SAĞLIK BAKANLIĞI İSTANBUL GÖZTEPE EĞİTİM VE ARAŞTIRMA HASTANESİ, İÇ HASTALIKLARI ASİSTAN DOKTOR
2011 - 2012
2011 - 2012PRATİSYEN DOKTOR
KIRKLARELİ KOFÇAZ TOPLUM SAĞLIĞI MERKEZİ, PRATİSYEN DOKTOR
Makaleler
Tümü (85)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (59)
ESCI (7)
Scopus (52)
TRDizin (24)
Diğer Yayınlar (10)
2025
20251. Hastanede Yatan Yaşlı Hastalarda Sarkopenı̇ Prevalansı Ve Malnütrı̇syon ı̇le İlı̇şkı̇sı̇
Kaçar M., UZUNLULU M., Eken E., Başcı S.
Hitit medical journal (Online)
, cilt.7, sa.3, ss.306-313, 2025 (TRDizin)
2025
20252. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?
ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science
, cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)
2025
20253. Analysis of peripheral stem cell mobilization research progress (2000–2023) based on bibliometric data
BAŞCI S., NAMDAROĞLU S., Batgi H.
Transfusion and Apheresis Science
, cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)
2025
20254. CD34+ Hematopoietik Kök Hücrelerin Cryofit® DMSO Kullanılarak Kriyoprezervasyonu ve Sonuçları
Başcı S., BATGİ H., NAMDAROGLU S.
Hitit medical journal (Online)
, cilt.7, sa.2, ss.273-279, 2025 (TRDizin)
2025
20255. Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization
Bakirtas M., Ulu B. U., Yigenoglu T. N., BAŞCI S., Kilinc A., Darcin T., et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY
, cilt.47, sa.1, 2025 (ESCI, Scopus)
2024
20246. Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting
NAMDAROĞLU S., BAŞCI S., Aslan Candır B., Yaman S., Yiğenoğlu T. N., Bahsi T., et al.
Journal of Clinical Medicine
, cilt.13, sa.17, 2024 (SCI-Expanded, Scopus)
2024
20247. Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?
Yaman S., Bozan E., Secilmis S., Candir B. A., KILINÇ A., BAŞCI S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.63, sa.4, 2024 (SCI-Expanded, Scopus)
2024
20248. Relaps / Refrakter T Hücreli Lenfomada Brentuximab Vedotin Monoterapisi- Gerçek Yaşam Verisi
Darçın T., Serin İ., Uğur M. C., Ekinci Ö., Hindilerden İ. Y., Akpınar S., et al.
Hitit medical journal (Online)
, cilt.6, sa.2, ss.186-192, 2024 (TRDizin)
2024
20249. Is neutropenic fever an obstacle to effective stem cell harvesting?
BAŞCI S., BOZAN E., YAMAN S., UNCU ULU B., BAKIRTAŞ M., YİĞENOĞLU T. N., et al.
ASIAN JOURNAL OF TRANSFUSION SCIENCE
, cilt.18, sa.21, 2024 (ESCI, Scopus)
2024
202410. Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience
Yaman S., BAŞCI S., Bozan E., Secilmis S., Candir B. A., Yigenoglu T. N., et al.
CLINICAL TRANSPLANTATION
, cilt.38, sa.6, 2024 (SCI-Expanded, Scopus)
2023
202311. The Turkish perspective on apheresis activity: The Turkish apheresis registry report
Ozatli D., Giden A. O., ERKURT M. A., Korkmaz S., Basci S., Ulas T., et al.
Transfusion and Apheresis Science
, cilt.62, sa.2, 2023 (SCI-Expanded, Scopus)
2023
202312. The effect of pre-conditioning immunoglobulin and absolute lymphocyte count on the outcomes of allogeneic hematopoietic cell transplantation
Kaçmaz M., Başci S., Ilhan G., Yiğenoğlu T. N., Çakar M. K., Dal M. S., et al.
Transplant Immunology
, cilt.76, 2023 (SCI-Expanded, Scopus)
2023
202313. Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey
Bakırtaş M., Dal M. S., Yiğenoğlu T. N., Giden A. O., Serin I., Başcı S., et al.
Journal of Chemotherapy
, cilt.35, sa.6, ss.563-569, 2023 (SCI-Expanded, Scopus)
2023
202314. The Timing of Granulocyte Colony-Stimulating Factor in Hematopoietic Stem Cell Transplant in the Pandemic
Kaçmaz M., Başci S., Yiğenoğlu T. N., Çakar M. K., Dal M. S., ALTUNTAŞ F.
Eastern Journal of Medicine
, cilt.28, sa.4, ss.726-731, 2023 (Scopus, TRDizin)
2022
202215. Prognostic value of neutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, lactate dehydrogenase, and mean platelet volume in the diagnosis of patients with diffuse large B-cell lymphoma
BAKIRTAŞ M., BAŞCI S., ASLAN CANDIR B., UNCU ULU B., YAMAN S., YİĞENOĞLU T. N., et al.
EGYPTIAN JOURNAL OF HAEMATOLOGY
, cilt.47, sa.4, ss.233-238, 2022 (Hakemli Dergi)
2022
202216. Face masks and polycythemia is the standard hemoglobin cutoff valid in the pandemic?
Yaman S., BAŞCI S., Turan G., Ulu B. U., Yigenoglu T. N., Bahsi T., et al.
IRAQI JOURNAL OF HEMATOLOGY
, cilt.11, sa.2, ss.130-133, 2022 (ESCI)
2022
202217. Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?
Ulu B. U., Başcı S., Bakırtaş M., Yiğenoğlu T. N., Batgi H., Yıldız J., et al.
LEUKEMIA RESEARCH
, cilt.115, 2022 (SCI-Expanded, Scopus)
2022
202218. Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies
Yaman S., Başcı S., Turan G., Ulu B. U., Yiğenoğlu T. N., Dal M. S., et al.
Clinical Lymphoma, Myeloma and Leukemia
, cilt.22, sa.2, 2022 (SCI-Expanded, Scopus)
2022
202219. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
Uncu Ulu B., Dal M. S., Yönal Hindilerden İ., Akay O. M., MEHTAP Ö., Büyükkurt N., et al.
Journal of Chemotherapy
, cilt.34, sa.3, ss.190-198, 2022 (SCI-Expanded, Scopus)
2022
202220. Nivolumab as a bridge to allogeneic hematopoietic stem cell transplantation is associated with improved survival
Iskender D., Çakar M., Dal M., Baysal N., Merdin A., Bakirtas M., et al.
European Review for Medical and Pharmacological Sciences
, cilt.26, sa.3, ss.957-965, 2022 (SCI-Expanded, Scopus)
2022
202221. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Başcı S., Ata N., ALTUNTAŞ F., Yiğenoğlu T. N., Dal M. S., Korkmaz S., et al.
Internal and Emergency Medicine
, cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded, Scopus)
2022
202222. Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients
Bakirtas M., Yigenoglu T. N., BAŞCI S., Ulu B. U., Yaman S., Cakar M. K., et al.
IRAQI JOURNAL OF HEMATOLOGY
, cilt.11, sa.1, ss.7-12, 2022 (ESCI)
2022
202223. Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation
Iskender D., Ibanoǧlu M., Seçilmiş S., Baysal N., Çakar M., Dal M., et al.
European Review for Medical and Pharmacological Sciences
, cilt.26, sa.3, ss.996-1003, 2022 (SCI-Expanded, Scopus)
2021
202124. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
Yiğenoğlu T. N., Başcı S., Şahin D., Ulaş T., Dal M. S., Korkmaz S., et al.
Transfusion and Apheresis Science
, cilt.60, sa.6, 2021 (SCI-Expanded, Scopus)
2021
202125. Does myeloma genetic have an effect on stem cell mobilization?
Başcı S., Yiğenoğlu T. N., Yaman S., Bozan E., Ulu B. U., Bakırtaş M., et al.
Transfusion and Apheresis Science
, cilt.60, sa.6, 2021 (SCI-Expanded, Scopus)
2021
202126. High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors
Yildiz J., Ulu B. U., Yigenoglu T. N., Basci S., Bakirtas M., Sahin D., et al.
Journal of B.U.ON.
, cilt.26, sa.6, ss.2531-2536, 2021 (SCI-Expanded, Scopus)
2021
202127. A Case of Hypopharyngeal Cancer Associated With Fanconi Anemia: A Helical Tomotherapy Experience
Kavak G., BAŞCI S., Türker Kekilli E., DAL M. S., Karakaya E.
CUREUS
, cilt.13, sa.11, 2021 (ESCI)
2021
202128. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma
Ulu B. U., Yiğenoğlu T. N., Başcı S., Bakırtaş M., Şahin D., Darçın T., et al.
Leukemia Research
, cilt.110, 2021 (SCI-Expanded, Scopus)
2021
202129. Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?
UNCU ULU B., YİĞENOĞLU T. N., ŞAHİN D., BAŞCI S., İSKENDER D., Adaş Y., et al.
CUREUS
, cilt.13, sa.11, ss.19462, 2021 (ESCI)
2021
202130. Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study
Merdin A., Dal M. S., Kizil Çakar M., Bahsi T., Düzkale N., Yildiz J., et al.
Medicine (United States)
, cilt.100, sa.41, 2021 (SCI-Expanded, Scopus)
2021
202131. Consolidation With Autologous Stem Cell Transplantation In Patients With Primary Central Nervous System Lymphoma
UNCU ULU B., ŞAHİN D., YİĞENOĞLU T. N., DARÇIN T., BAKIRTAŞ M., BAŞCI S., et al.
ACTA ONCOLOGICA TURCICA
, cilt.54, sa.2, ss.152-158, 2021 (TRDizin)
2021
202132. Can body shape index indicate obesity-associated inflammation and cardiovascular diseases in stage 3-4 chronic kidney disease patients?
ŞAŞAK KUZGUN G., Isbilen B., BAŞCI S., koçanoğlu a., BAKAN A., İŞMAN F. K.
Ukrainian Journal of Nephrology and Dialysis
, cilt.4, sa.72, ss.60-66, 2021 (Scopus)
2021
202133. The outcome of diffuse large B cell lymphoma patients in adolescent and young adult age group
Başcı S., Bakırtaş M., Yiğenoğlu T. N., Ulu B. U., Batgi H., Yıldız J., et al.
Journal of Adolescent and Young Adult Oncology
, cilt.10, sa.4, ss.483-487, 2021 (SCI-Expanded, Scopus)
2021
202134. Return to Work of Lymphoma Survivors after Autologous Stem Cell Transplantation: A Single-center Cross-sectional Study
Yildiz J., Ulu B. U., BAŞCI S., Darcin T., Bakirtas M., Sahin D., et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL
, cilt.23, sa.7, 2021 (SCI-Expanded)
2021
202135. Clinical findings and immunophenotypic profile of plasma cell leukemia: a retrospective study in a comprehensive cancer center in Turkey
ÖZCAN N., BAŞCI S., ÖZCAN E., BAKIRTAŞ M., DAL M. S., KIZIL ÇAKAR M., et al.
Medicine Science , cilt.10, sa.2, ss.455-461, 2021 (TRDizin)
2021
202136. Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old
UNCU ULU B., YİĞENOĞLU T. N., BAŞCI S., BAKIRTAŞ M., ŞAHİN D., DARÇIN T., et al.
Medical Laboratory Technology Journal , cilt.7, sa.1, ss.18-25, 2021 (Hakemli Dergi)
2021
202137. Effect of the amount of Autologous Hematopoietic Stem Cells on Survival and Engraftment in Multiple Myeloma
BATGİ H., BAŞCI S., Bakirtas M., Ulu B. U., Yigenoglu T. N., Yildiz J., et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL
, cilt.23, sa.5, 2021 (SCI-Expanded)
2021
202138. COVID-19 in hematopoietic cell transplant recipients
ALTUNTAŞ F., Ata N., Yigenoglu T. N., Bascı S., Dal M. S., Korkmaz S., et al.
Bone Marrow Transplantation
, cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded, Scopus)
2021
202139. Akut Myeloid Lösemi ve Obezite Arasındaki İlişki
BAŞCI S., YAMAN S., Durmuşoğlu E., YİĞENOĞLU T. N., UNCU ULU B., BAKIRTAŞ M., et al.
Acta Oncologica Turcica
, cilt.54, sa.1, ss.92-97, 2021 (TRDizin)
2021
202140. Efficacy of reduced dose melphalan conditioning for multiple myeloma patients undergoing autologous stem cell transplantation: in the era of combined induction with novel agents
UNCU ULU B., BAKIRTAŞ M., YİĞENOĞLU T. N., BAŞCI S., YILDIZ J., ŞAHİN D., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE
, cilt.4, sa.2, ss.203-208, 2021 (TRDizin)
2021
202141. Evaluation of seasonality in the diagnosis of diffuse large B cell lymphoma in Turkey
BAKIRTAŞ M., UNCU ULU B., BAŞCI S., DARÇIN T., YILDIZ J., SEÇİLMİŞ S., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE
, cilt.4, sa.2, ss.123-126, 2021 (TRDizin)
2021
202142. The effect of bulky mass on prognosis in diffuse large-B-cell lymphoma: still poor?
Başcı S., Yiğenoğlu T. N., Bakırtaş M., Uncu Ulu B., Yaman S., Dal M. S., et al.
Leukemia Research
, cilt.102, 2021 (SCI-Expanded, Scopus)
2021
202143. The outcome of COVID-19 in patients with hematological malignancy
Yigenoglu T. N., Ata N., Altuntaş F., Bascı S., Dal M. S., Korkmaz S., et al.
Journal of Medical Virology
, cilt.93, sa.2, ss.1099-1104, 2021 (SCI-Expanded, Scopus)
2021
202144. Old is bad? The effect of age on peripheral stem cell mobilization and transplantation outcomes
Başcı S., Bakırtaş M., Uncu Ulu B., Yiğenoğlu T. N., Yaman S., Batgi H., et al.
Transfusion and Apheresis Science
, cilt.60, sa.1, 2021 (SCI-Expanded, Scopus)
2021
202145. Convalescent plasma therapy in patients with COVID-19
ALTUNTAŞ F., Ata N., Yigenoglu T. N., Bascı S., Dal M. S., Korkmaz S., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
, cilt.60, sa.1, ss.102955, 2021 (SCI-Expanded, Scopus)
2021
202146. Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: A single center experience
Batgi H., Basci S., Dal M. S., Kizil Çakar M., Uncu Ulu B., Yigenoglu T. N., et al.
Turkish Journal of Medical Sciences
, cilt.51, sa.2, ss.685-692, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202147. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study
Yildiz J., Ulu B., Yiğenoğlu T., Başçi S., Darçin T., Bakirtaş M., et al.
European Review for Medical and Pharmacological Sciences
, cilt.25, sa.10, ss.3655-3660, 2021 (SCI-Expanded, Scopus)
2021
202148. A Comparison of the BEAM and BuCyE Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma: A Single-Center Experience
BATGİ H., BAŞCI S., YAMAN S., UNCU ULU B., YİĞENOĞLU T. N., DAL M. S., et al.
ACTA ONCOLOGICA TURCICA
, cilt.54, sa.3, ss.87-95, 2021 (TRDizin)
2021
202149. COVID-19 clinical course and blood groups: Turkish population-based study
Dal M. S., Ata N., ALTUNTAŞ F., Başci S., Yiğenoğlu T. N., Korkmaz S., et al.
Turkish Journal of Medical Sciences
, cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202050. Tyrosine kinase inhibitors and COVID-19
Semih B., Tuğçe Nur Y., Mehmet Sinan D., Serdal K., Burhan T., Fevzi A.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.8, ss.2072-2073, 2020 (SCI-Expanded, Scopus)
2020
202051. Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents
BAŞCI S., YİĞENOĞLU T. N., UNCU ULU B., BAKIRTAŞ M., ŞAHİN D., DARÇIN T., et al.
Medical Laboratory Technology Journal , cilt.6, sa.2, ss.92-99, 2020 (Hakemli Dergi)
2020
202052. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience
Batgi H., Merdin A., Dal M. S., Kızıl Çakar M., Yıldız J., Başçı S., et al.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.8, ss.1857-1863, 2020 (SCI-Expanded, Scopus)
2020
202053. Is Autologous Stem Cell Transplantation a Risk For Divorce in Lymphoma Survivors?
YILDIZ J., YİĞENOĞLU T. N., MERDİN A., UNCU ULU B., BAŞCI S., DARÇIN T., et al.
ACTA ONCOLOGICA TURCICA
, cilt.53, sa.3, ss.469-474, 2020 (TRDizin)
2020
202054. Erişkin Başlangıçlı Langerhans Hücreli Histiyositozis Tedavisinde Vinblastin Kemoterapisinin Yeri – Ankara Onkoloji Hastanesi Deneyimi
TETİK A., UNCU ULU B., BAKIRTAŞ M., YİĞENOĞLU T. N., YILDIZ J., BAŞCI S., et al.
ACTA ONCOLOGICA TURCICA
, cilt.53, sa.3, ss.492-499, 2020 (TRDizin)
2020
202055. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
Başcı S., Ata N., ALTUNTAŞ F., Yiğenoğlu T. N., Dal M. S., Korkmaz S., et al.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded, Scopus)
2020
202056. The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome
Secilmis S., Bozan E., Darcin T., Yaman S., Baysal N. A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.20, 2020 (SCI-Expanded, Scopus)
2020
202057. Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience
Secilmis S., Bozan E., Darcin T., Yaman S., Yigenoglu T., Ulu B. U., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.20, 2020 (SCI-Expanded, Scopus)
2020
202058. One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma
Yaman S., Yigenoglu T. N., Ulu B. U., Bozan E., Secilmis S., Darcin T., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.20, 2020 (SCI-Expanded, Scopus)
2020
202059. Adult aplastic anemia patients can maintain remission after allogeneic hematopoietic stem cell transplantation in a mixed chimeric state
BAŞCI S., YİĞENOĞLU T. N., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.
Journal of Surgery and Medicine , cilt.4, sa.9, ss.729-732, 2020 (Hakemli Dergi)
2020
202060. The Relationship Between ABO and Rh Blood Groups with Acute Lymphoblastic Leukemia
BAŞCI S., YİĞENOĞLU T. N., ŞAHİN D., Saygılı Ö., BAKIRTAŞ M., UNCU ULU B., et al.
ACTA ONCOLOGICA TURCICA
, cilt.53, sa.2, ss.357-361, 2020 (TRDizin)
2020
202061. Blood group A is a negative risk factor for peripheric blood stem cell mobilization in allogeneic donors
YİĞENOĞLU T. N., BAKIRTAŞ M., BAŞCI S., UNCU ULU B., ŞAHİN D., KILINÇ A., et al.
Medical Science and Discovery , cilt.7, sa.6, ss.505-508, 2020 (Hakemli Dergi)
2020
202062. The relationship between blood groups and acute myeloid leukemia
ŞAHİN D., BAŞCI S., TEMİZEL TAŞCI A., UNCU ULU B., BATGİ H., BAYSAL N. A., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE
, cilt.3, sa.3, ss.221-224, 2020 (TRDizin)
2020
202063. Second allogeneic stem cell transplantation in acute leukemia patients: single-centre experience
BAKIRTAŞ M., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., ÖZCAN N., İSKENDER D., et al.
JURNAL TEKNOLOGI LABORATORIUM , cilt.9, sa.1, ss.87-96, 2020 (Hakemli Dergi)
2020
202064. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor
Merdin A., Çakar M. K., Dal M. S., Mert D., Yıldız J., Başçı S., et al.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.4, ss.929-932, 2020 (SCI-Expanded, Scopus)
2020
202065. The Value Of International Staging System In Predicting Survival of Multiple Myeloma Patients With Renal Failure
YİĞENOĞLU T. N., BAŞCI S., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.
Dicle Tıp Dergisi
, cilt.47, sa.2, ss.237-242, 2020 (TRDizin)
2020
202066. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors
Yiğenoğlu T. N., Başcı S., Bakırtaş M., Ulu B. U., Kılınç A., Şahin D., et al.
Transfusion and Apheresis Science
, cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)
2020
202067. The effect of smoking on stem cell mobilization in allogeneic donors
YİĞENOĞLU T. N., BAŞCI S., ŞAHİN D., BAKIRTAŞ M., KILINÇ A., UNCU ULU B., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE
, cilt.3, sa.3, ss.291-294, 2020 (TRDizin)
2020
202068. Inferior prognosis in poor mobilizing myeloma patients
Yiğenoğlu T. N., Başcı S., Ulu B. U., Bakırtaş M., Kılınç A., Şahin D., et al.
Transfusion and Apheresis Science
, cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)
2020
202069. Evaluation of seasonal changes in the diagnosis of acute leukemia in Turkey
Başci S.
Medical Science and Discovery , cilt.7, ss.501-504, 2020 (Hakemli Dergi)
2020
202070. OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA
BAKIRTAŞ M., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., ÖZCAN N., KIZIL ÇAKAR M., et al.
SANAMED , cilt.15, sa.1, ss.15-19, 2020 (Hakemli Dergi)
2020
202071. Stem Cell Transplantation and Medical Tourism at Ankara Oncology Training and Research Hospital
ŞAHİN D., YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., DARÇIN T., BAKIRTAŞ M., et al.
ACTA ONCOLOGICA TURCICA
, cilt.53, sa.1, ss.113-116, 2020 (TRDizin)
2020
202072. Otolog Kök Hücre Nakli Sonrası Nüks Multipl Myelom Hastalarında Allojenik Kök Hücre Transplantasyonu: Tek Merkez Deneyimi
BAKIRTAŞ M., UNCU ULU B., BAŞCI S., YİĞENOĞLU T. N., YILDIZ J., MERDİN A., et al.
ACTA ONCOLOGICA TURCICA
, cilt.53, sa.1, ss.108-112, 2020 (TRDizin)
2020
202073. The Outcome of Autologous Stem Cell Transplantation in Adolescent and Young Adult Patients with Multiple Myeloma
YİĞENOĞLU T. N., BAŞCI S., UNCU ULU B., BAKIRTAŞ M., ŞAHİN D., DARÇIN T., et al.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
, cilt.4, sa.1, ss.79-83, 2020 (ESCI, Scopus, TRDizin)
2020
202074. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma
Çakar M. K., Tekgündüz E., Dal M. S., Merdin A., Başçı S., Uğur B., et al.
Journal of Oncology Pharmacy Practice
, cilt.26, sa.2, ss.273-278, 2020 (SCI-Expanded, Scopus)
2020
202075. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations
Merdin A., Dal M. S., Çakar M. K., Yildiz J., Ulu B. U., Batgi H., et al.
Medicine (United States)
, cilt.99, sa.14, 2020 (SCI-Expanded, Scopus)
2019
201976. Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience
Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., BAŞCI S., Merdin A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, 2019 (SCI-Expanded, Scopus)
2019
201977. The Relationship Between ABO and Rhesus Blood Groups and Acute Lymphoblastic Leukemia
Sahin D., Yigenoglu T., Darcin T., BAŞCI S., Saygili O., Ulu B., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, 2019 (SCI-Expanded, Scopus)
2019
201978. Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., BAŞCI S., Merdin A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, 2019 (SCI-Expanded, Scopus)
2017
201779. Handgrip Strength and Serum Uric Acid Levels are Associated with Dialysis-Malnutrition Scores in Chronic Hemodialysis Patients
BAŞCI S., ÖZKÖK A., KAÇAR M., BİLGİN S., ODABAŞ A. R.
TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL
, cilt.26, sa.3, ss.323-332, 2017 (Scopus, TRDizin)
2017
201780. The relationship between vitamin D level and mean platelet volume in kidney transplant recipients
ŞAŞAK KUZGUN G., ORAL A., BAŞCI S.
Medeniyet medical journal
, cilt.32, sa.2, ss.106-110, 2017 (Scopus, TRDizin)
2017
201781. Effects of the Clinical and Biochemical Features of Patients with Treatment-Resistant Primary Nephrotic Syndrome on Renal Survival
BİLGİN S., ÖZKÖK A., KÖSTEK O., BAŞCI S., ÖZKANLI S. Ş., ODABAŞ A. R.
TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL
, cilt.26, sa.1, ss.79-85, 2017 (Scopus, TRDizin)
2016
201682. Synthetic Cannabinoids Associated Acute Kidney Injury: Case Report
ELÇİOĞLU Ö. C., BAŞCI S., BAKAN A., AYDIN BAHAT K., ÖZLÜK M. Y., KILIÇASLAN I., et al.
Turkiye Klinikleri Journal of Nephrology , cilt.10, sa.2, ss.43-46, 2016 (Hakemli Dergi)
2016
201683. Chronic rhinosinusitis, endothelial dysfunction, and atherosclerosis
ELÇİOĞLU Ö. C., Afsar B., Bakan A., Takir M., Ozkok A., Oral A., et al.
American Journal of Rhinology and Allergy
, cilt.30, sa.3, 2016 (SCI-Expanded, Scopus)
2015
201584. Hyperuricemia is associated with progression of IgA nephropathy
Bakan A., Oral A., ELÇİOĞLU Ö. C., Takir M., Kostek O., Ozkok A., et al.
International Urology and Nephrology
, cilt.47, sa.4, ss.673-678, 2015 (SCI-Expanded, Scopus)
2013
201385. Postpartum Stanford Type A Aortic Dissection: A Case Report and Review of the Literature
BALBAY E., BAŞCI S., BOZKURT İ., ÖZKÖK A., DOĞRUYOL S., ERKUŞ SİRKECİ E., et al.
Cardiology Research
, cilt.4, sa.3, ss.129-132, 2013 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. LENALİDOMİD TEDAVİSİ ALAN İZOLE 5Q DELESYONU OLAN MYELODİSPLASTİK SENDROM HASTASININ EKSTRAMEDULLER AKUT MYELOİD LÖSEMİYE TRANSFORMASYONU: OLGU SUNUMU
YİĞENOĞLU T. N., BAŞCI S., BAKIRTAŞ M., UNCU ULU B., ŞAHİN D., DARÇIN T., et al.
II. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Kıbrıs (Kktc), 7 - 09 Şubat 2019, (Özet Bildiri)
Kitaplar
2024
20241. Allogeneic Hematopoietic Stem Cell Transplant
Batgi H., Başcı S.
Comprehensive Hematology and Stem Cell Research, Nima Rezaei, Editör, Elsevier, Amsterdam, ss.1030-1060, 2024
2024
20242. Diffuse Large B Cell Lymphoma
Başcı S.
Comprehensive Hematology and Stem Cell Research, Nima Rezaei, Editör, Elsevier, Amsterdam, ss.1500-1525, 2024
2021
20213. Kalp ve Damar Hastalıklarında Terapötik Aferez
BAŞCI S., DAL M. S.
Aferez İlkeler ve Uygulamalar Cilt 1: Terapötik Aferez, Altuntaş Fevzi, Dal Mehmet Sinan, Çakar, Merih Kızıl, Yiğenoğlu Tuğçe Nur, Editör, MediHealth Academy Yayıncılık, Ankara, ss.199-223, 2021
2020
20204. Hiperviskozite Sendromu
BAŞCI S.
Hematolojik Aciller, Dal Mehmet Sinan, Editör, MediHealth Academy Yayıncılık, Ankara, ss.77-80, 2020
2020
20205. Recent Advances in Chronic Lymphocytic Leukemia
BAŞCI S.
Recent Advances in Hematology, Dal Mehmet Sinan, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.103-107, 2020
2020
20206. Recent Advances in Chronic Myeloid Leukemia
BAŞCI S.
Recent Advances in Hematology, Dal Mehmet Sinan, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.109-113, 2020
Bilimsel Dergilerdeki Faaliyetler
2021 - Devam Ediyor
2021 - Devam EdiyorACTA ONCOLOGICA TURCICA
Yardımcı Editör/Bölüm Editörü
Bilimsel Yayınlarda Hakemlikler
Haziran 2023
Haziran 2023Journal of Adolescent and Young Adult Oncology
SCI-E Kapsamındaki Dergi
Şubat 2023
Şubat 2023DRUGS IN R AND D
SCI-E Kapsamındaki Dergi
Ocak 2023
Ocak 2023JOURNAL OF CLINICAL MEDICINE
SCI-E Kapsamındaki Dergi
Ocak 2023
Ocak 2023HEMATOLOGY
SCI-E Kapsamındaki Dergi
Aralık 2022
Aralık 2022CELLS
SCI-E Kapsamındaki Dergi
Ekim 2022
Ekim 2022JOURNAL OF PERSONALIZED MEDICINE
SCI-E Kapsamındaki Dergi
Ağustos 2022
Ağustos 2022SAGE Open Medicine
SCI-E Kapsamındaki Dergi
Ağustos 2022
Ağustos 2022SCIENTIFIC REPORTS
SCI-E Kapsamındaki Dergi
Ağustos 2022
Ağustos 2022CANCER INVESTIGATION
SCI-E Kapsamındaki Dergi
Mayıs 2022
Mayıs 2022DIABETES, METABOLIC SYNDROME AND OBESITY: TARGETS AND THERAPY
SCI-E Kapsamındaki Dergi
Nisan 2022
Nisan 2022LEUKEMIA RESEARCH
SCI-E Kapsamındaki Dergi
Mart 2022
Mart 2022TRANSFUSION AND APHERESIS SCIENCE
SCI-E Kapsamındaki Dergi
Mart 2022
Mart 2022JOURNAL OF OBSTETRICS AND GYNAECOLOGY
SCI-E Kapsamındaki Dergi
Şubat 2022
Şubat 2022CANCER MANAGEMENT AND RESEARCH
SCI-E Kapsamındaki Dergi
Ocak 2022
Ocak 2022MEDICAL SCIENCE MONITOR
SCI-E Kapsamındaki Dergi
Aralık 2021
Aralık 2021JOURNAL OF MEDICAL VIROLOGY
SCI-E Kapsamındaki Dergi
Kasım 2021
Kasım 2021JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
SCI-E Kapsamındaki Dergi
Temmuz 2021
Temmuz 2021THERAPEUTIC ADVANCES IN CHRONIC DISEASE
SCI-E Kapsamındaki Dergi
Davetli Konuşmalar
Şubat 2025
Şubat 2025Yeni Tanı Transplanta Uygun Olan veya Olmayan Myeloma hastalarında Lenalidomid’in Yeri
Konferans
8. Hematolojik Nadir Hastalıklar Kongresi-Türkiye
Kasım 2024
Kasım 2024Multipl Miyelomda CAR T-Hücre Tedavisinin Optimizasyonu: Öğrenilen Dersler ve Gelecek Yönelimler
Konferans
Hematoloji Uzmanlık Derneği Ulusal Kongresi-Türkiye
Kasım 2024
Kasım 2024Multiple Miyeloma: MRD Ne Zaman Bakalım? Çalışmalar ve Gerçek Dünya Farklı Mı?
Konferans
VI. ULUSLARARASI HEMATOLOJİ EĞİTİM VE ARAŞTIRMA KONGRESİ-Türkiye
Eylül 2024
Eylül 2024CAR T Hücre İnfüzyon Öncesi ve Sonrası Yapılması Gereken Testler ve Hücrelerin İnfüzyona Hazırlanması
Konferans
Transplantasyon ve Hücresel Tedaviler Derneği-Türkiye
Aralık 2023
Aralık 2023II.TRANSPLANTASYON VE HÜCRESEL TEDAVİLER DERNEĞİ KONGRESİ
Konferans
II.TRANSPLANTASYON VE HÜCRESEL TEDAVİLER DERNEĞİ KONGRESİ-Türkiye
Kasım 2023
Kasım 2023RR B-ALL'de Hücresel Bazlı Gen Tedavileri
Konferans
Hematoloji Eğitim ve Araştırma Derneği -Türkiye
Kasım 2023
Kasım 2023